Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > Top Gainers
View:
Post by retiredcf on Aug 09, 2022 7:01am

Top Gainers

Symbol/ Company Price $ Change $ Volume
Data delayed at least 15 minutes, as of 08/08/2022 4:00 PM ET | All market data delayed
Canopy Growth Corp
$4.22 CAD +$0.72(20.57%) 4.03M
Westport Fuel Systems Inc
$1.98 CAD (16.47%) 568.00K
Capstone Copper Corp
$3.10 CAD (15.67%) 3.55M
Touchstone Exploration Inc
$1.36 CAD (15.25%) 522.21K
Thinkific Labs Inc
$2.19 CAD (13.47%) 168.73K
Bombardier Inc
$32.83 CAD (12.78%) 20.32K
Nuvei Corp
$54.10 CAD (11.41%) 619.23K
Opsens Inc
$2.75 CAD (11.34%) 137.57K
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities